Author:
Kim Sang-We,Suh Cheolwon,Lee Sang Do,Kim Woo Sung,Kim Dong Soon,Kim Won Dong,Lee Jung Sin
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference28 articles.
1. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;Browder;Cancer Res.,2000
2. Antiangiogenic chemotherapeutic agents;Schirner;Cancer Metastasis Rev.,2000
3. Paclitaxel: what schedule? What dose?;Arbuck;J. Clin. Oncol.,1994
4. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial;Bonomi;J. Clin. Oncol.,2000
5. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin;Rowinsky;Clin. Cancer Res.,1999
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献